Share Talk highlighted thirty-one, yes thirty-one new company “52-wk high” across our social media platforms, five in the last trading day of the week. Who said private/retail investors do not
4d Pharma (DDDD) proved once again that 2020 has been the blow the lights out year for pharma companies of all persuasions, not just those on the Covid-19 bandwagon.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Stocks that may or may not make tomorrow’s papers, but should.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk highlighted nine, yes nine new company “52-wk high” across our social media platforms, who said private/retail investors do not like the small micro-cap space.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
On 26 June 2020 the Company announced a Development Agreement with a global pharmaceutical company (“GlobalCo”). GlobalCo has now consented to the use of its name in the announcement, an
Share Talk highlighted eight new company 52-wk high across our platform and liquidity, volume continues to grow across the small micro-cap market. Launching a new #BulletinBoardHeroes, USA Penny Stock Chart
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Here is our pick of
